首页 | 本学科首页   官方微博 | 高级检索  
     

三腔胃肠管行早期肠内营养应用于肝门部胆管癌患者的临床价值
引用本文:胡月娥. 三腔胃肠管行早期肠内营养应用于肝门部胆管癌患者的临床价值[J]. 国际医药卫生导报, 2017, 23(1). DOI: 10.3760/cma.j.issn.1007-1245.2017.01.0043
作者姓名:胡月娥
作者单位:266300,胶州市人民医院
摘    要:目的 分析三腔胃肠管行早期肠内营养应用于肝门部胆管癌患者根治术后的临床价值.方法 选取本院于2012年6月至2014年6月收治的42例患有肝门部胆管癌的患者作为研究对象,将其按照入院前后分为两组,分别为普通胃管组和三腔胃肠管组,术后进行相同的EN疗法.对比分析两组患者肛门恢复排气的时间、腹泻、呕吐、恶心、切口感染、腹腔感染、肺部感染、胃液的引流量及其术后第8d时肝、肾功能等临床指标.结果 普通胃管组患者肺部的感染率为7.0%,明显比三腔胃肠管组的1.0%高,经统计分析,差异有统计学意义(P<0.05);三腔胃肠管组患者的呕吐和恶心的发生率为3.0%,明显比普通胃管组的12.0%低,经统计分析,差异有统计学意义(P<0.05).两组患者从肛门恢复排气时间、胃液引流量、切口感染率、腹腔感染率等并发症发生率方面,经统计分析,差异无统计学意义(均P> 0.05).两组患者均于术后第8d对肝功能和肾功能进行复查,与术前相比,其胆红素含量显著下降,且肝功能明显恢复,而肾功能表现均正常,经统计分析,差异无统计学意义(P>0.05).结论 肝门部胆管癌患者根治术后应用三腔胃肠管行EEN时具有安全可靠、耐受性好等优势,同时还可降低术后并发症的发生.

关 键 词:肝门部胆管癌  肠内营养  三腔胃肠管  临床价值

Clinical value of early enteral nutrition through Freka Trelumina in treatment of patients with hilar cholangiocarcinoma
Hu Yue,#;e. Clinical value of early enteral nutrition through Freka Trelumina in treatment of patients with hilar cholangiocarcinoma[J]. International Medicine & Health Guidance News, 2017, 23(1). DOI: 10.3760/cma.j.issn.1007-1245.2017.01.0043
Authors:Hu Yue&#  e
Abstract:Objective To analyze the clinical value of early enteral nutrition through Freka Trelumina in the treatment of patients with hilar cholangiocarcinoma after radical surgery.Methods 42 patients with hilar cholangiocarcinoma treated at our hospital from June,2012 to June,2014 were selected as study objects and were divided into an ordinary tube group and a Freka Trelumina group according to their admission times.After the operation,both groups took the same enteral nutrition.The anal exhaustion time,diarrhea,vomiting,nausea,incision infection,abdominal infection,lung infection,and drainage volume of gastric juice and the clinical indicators of liver and kidney functions 8 days after operation were analyzed and compared between these two groups.Results The pulmonary infection rate was 7.0% in the ordinary tube group and was 1% in the Freka Trelumina group,with a statistical difference (P < 0.05).The incidence nausea and vomiting rate was 3.0% in the Freka Trelumina group and was 12.0% in the ordinary tube group,with a statistical difference (P < 0.05).igher than the ordinary tube group were low (P < 0.05).There were no statistical differences in the anal exhaustion time,the drainage volume of gastric juice,time,incision infection rate,abdominal infection rate,etc.between these two groups (P > 0.05).8 days after operation,the bilirubin content significantly decreased,the liver function was restored,and the renal function recover to normal in both groups,with no statistical differences (P > 0.05).Conclusions Early enteral nutrition through Freka Trelumina in the treatment of patients with hilar cholangiocarcinoma after radical surgery is safe,reliable and well tolerated and can reduce the incidence of postoperative complications.
Keywords:Hilar cholangiocarcinoma  Enteral nutrition  Freka Trelumina  Clinical value
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号